Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1472-1479

  Khorram, O ^a,b,c   Laughlin, G A ^a   Yen, S S C ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d Clayton Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RELEASING FACTOR[1-29]; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; METABOLISM; NITROGEN BALANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SKINFOLD THICKNESS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030997815     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.5.1472     Document Type: Article

References (27)

1. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. 1981 Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest. 67:1361-1369.
2. Rudman D. 1985 Growth hormone, body composition, and aging. J Am Geriatr Soc. 33:800-807.
3. Corpas E, Harman SM, Blackman MR. 1993 Human growth hormone and human aging. Endocr Rev, 14:20-39.
4. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
5. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab. 79:470-479.
6. Ho KY, Hoffman DM. 1993 Aging and growth hormone. Horm Res. 40:80-86.
7. Vance ML. 1990 Growth hormone for the elderly? N Engl J Med. 323:52-54.
8. Corpas E, Harman SM, Pineyro MA, Robetson R, Blackman MR. 1992 Growth hormone (GH)-releasing hormone (1-29) twice daily reverses the decreased GH and insulin-like growth factor-1 levels in old men. J Clin Endocrinol Metab. 75:530-535.
9. Blackman MR, Vittone J, Corpas E, et al. Growth hormone releasing hormone (GHRH) effects in healthy aging men. In: Bercu BB, Walker RF, eds. Growth hormone secretagogues. Serono Symp. New York: Springer; 403-413.
10. 2 on growth hormone secretion in normal men: dose-response relationships. Clin Pharmacol Ther. 10:627-633.
11. Steil GM, Volund A, Kahn SE, Bergman RN. 1993 Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Diabetes. 42:250-256.
12. Bergman RN, Beard JC, Chen M. 1986 The minimal modeling method. Assessment of insulin sensitivity and B cell function in vivo. Methods Diabetes Res. 2:15-34.
13. Holden JP, Bützow TL, Laughlin GA, Ho M, Morales AJ, Yen SSC. 1994 Regulation of insulin-like growth factor binding protein-1 (IGFBP-1) during the 24 hour metabolic clock and in response to hypoinsulinemia induced by fasting and sandostatin in normal women. J Soc Gynecol Invest. 2:38-44.
14. Carlsson LMS, Rowland AM, Clark RG, Gesundheit N, Wong WLT. 1991 Ligand-mediated immunofunctional assay for quantitation of GH-binding protein in human blood. J Clin Endocrinol Metab. 73:1216-1223.
15. Shuster S, Black MM, McVitie E. 1975 The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 93:639-643
16. Kaplan RM, Bush JW. 1982 Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol. 1:61-80.
17. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kopfer OJ. 1989 The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychol Res. 28:193-213.
18. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-E493.
19. Vance ML, Kaiser DL, Martha PN, et al. 1989 Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in men and a GH-deficient boy. J Clin Endocrinol Metab. 68:22-28.
20. Jones JI, Clemmons DR. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-138.
21. Maheshwari H, Sharma L, Baumann G. 1996 Decline of plasma growth hormone binding profein in old age. J Clin Endocrinol Metab. 81:995-997.
22. Baumann G. 1994 Growth hormone-binding proteins: state of the art. J Endocrinol. 141:1-6.
23. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KK. 1993 Effects of different estrogen formulations on insulin-like growth factor-1, growth hormone and growth hormone binding protein in postmenopausal women. Clin Endocrinol (Oxf). 39:561-567.
24. O'Sullivan AJ, Crampton L, Freund J, Ho KKY. Route of estrogen replacement confers distinct and divergent effects on energy metabolism and body composition in postmenopausal women [Abstract OR38-43]. Proc of the 77th Annual Meeting of The Endocrine Soc. 1995; 47.
25. Clemmons D. 1992 Editorial: role of insulin-like growth factor-1 in reversing catabolism. J Clin Endocrinol Metab. 75:1183-1185.
26. Kerkhopfs SM, Cauter EV, Onderbergen AV, Caufriez A, Thorner MD, Copinschi G. 1993 Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol. 264:E594-E598.
27. Marshall L, Mölle M, Böschen G, Steiger A, Fehm HL, Born J. 1996 Greater efficacy of episodic than continuous growth hormone-releasing hormone (GHRH) administration in promoting slow-wave sleep (SWS). J Clin Endocrinol Metab. 81:1009-1013.